The medical engineered materials market size has grown rapidly in recent years. It will grow from $25.24 billion in 2025 to $28.97 billion in 2026 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to rising adoption of implantable medical devices, expansion of surgical procedures, increased demand for advanced wound care products, availability of specialized medical polymers, integration of material science in healthcare design.
The medical engineered materials market size is expected to see rapid growth in the next few years. It will grow to $48.85 billion in 2030 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to increasing demand for next-generation implants, rising focus on regenerative medicine, expansion of personalized medical devices, growing use of sustainable medical materials, advancements in material engineering technologies. Major trends in the forecast period include increasing development of advanced biomaterials, rising use of customized medical polymers, growing demand for biocompatible and bioresorbable materials, expansion of engineered materials for implants, enhanced focus on material performance and safety.
The increasing volume of surgical procedures is anticipated to drive the expansion of the medical engineered materials market in the coming years. Surgical procedures are medical interventions that involve incisions or invasive techniques to diagnose or treat conditions affecting internal or external parts of the body. Growth in the number of surgeries directly increases the demand for materials used in surgical instruments, implantable devices, and minimally invasive interventions. Materials that are biocompatible and resistant to infection are critical to maintaining patient safety and improving clinical outcomes. At the same time, the need for customization and compliance with stringent regulatory requirements supports ongoing research and development activities, while cost considerations and technological progress continue to stimulate material innovation. For example, in June 2024, according to the American Society of Plastic Surgeons, a United States-based non-profit organization, minimally invasive procedures rose by 7% in 2023, exceeding the growth rate of traditional surgical procedures by 2%. Hand-related procedures, including carpal tunnel, arthritis, and trigger finger surgeries, reached 207,887 cases, representing a 2% increase compared to 2022. Therefore, the growing number of surgical procedures is contributing to the growth of the medical engineered materials market.
Major companies in the medical engineered materials market are investing in the development of new products to gain a competitive edge. Covestro AG, a Germany-based polymer materials company, introduced Makrolon 3638 polycarbonate in February 2023. This advanced material solution, tailored for healthcare and life sciences applications, exhibits high durability across a wide temperature range, from cryogenic to steam sterilization conditions. It features high impact strength and ductility, along with high chemical resistance, meeting medical-grade and biocompatibility standards. Suitable for skin contact applications, the material is also of food contact quality and can be sterilized using common methods in the healthcare sector.
In June 2023, STRATEC SE, a Germany-based healthcare technology company, completed the acquisition of Natech Plastics, Inc. for an undisclosed value. Through this transaction, STRATEC sought to enhance its footprint in the United States, broaden its customer portfolio, and capitalize on operational synergies in consumable technologies. Natech Plastics is a United States-based manufacturer specializing in the design and production of advanced polymer-based consumables used across medical technology, in vitro diagnostics, life sciences, consumer products, and specialized packaging applications.
Major companies operating in the medical engineered materials market are Evonik Industries AG, Covestro AG, BASF SE, Solvay SA, Saudi Basic Industries Corporation, Trelleborg AB, Koninklijke DSM N.V., Celanese Corporation, DuPont de Nemours Inc., Henkel AG & Co. KGaA, Huntsman Corporation, Momentive Performance Materials Inc., Nitto Denko Corporation, Recticel Ltd., Victrex plc, Ensinger GmbH, RTP Company, Foster Corporation, Zeus Industrial Products Inc., Saint-Gobain SA, Arkema SA, Eastman Chemical Company, Lubrizol Corporation, PolyOne Corporation, Quadrant AG, Röchling Group, DSM Biomedical, Invibio Ltd., Carpenter Technology Corporation, Heraeus Medical Components GmbH, CeramTec GmbH, Morgan Advanced Materials plc, Freudenberg Medical LLC.
Asia-Pacific was the largest region in the medical engineered materials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical engineered materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical engineered materials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the medical engineered materials market by increasing costs of imported specialty polymers, elastomers, adhesives, and processing equipment used in medical devices and disposables. North America and Europe are most affected due to dependence on imported high-performance materials, while Asia-Pacific faces cost pressure on export-driven material production. These tariffs are increasing material costs and affecting product pricing. However, they are also driving domestic material innovation, regional supplier development, and investment in localized biomaterial manufacturing.
The medical engineered materials market research report is one of a series of new reports that provides medical engineered materials market statistics, including medical engineered materials industry global market size, regional shares, competitors with a medical engineered materials market share, detailed medical engineered materials market segments, market trends and opportunities, and any further data you may need to thrive in the medical engineered materials industry. This medical engineered materials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Medical engineered materials, often referred to as biomaterials, denote substances that are specifically crafted to meet particular or customized criteria, aiming to interact with biological systems for therapeutic or diagnostic purposes in the field of medicine. Serving as a crucial link between science, technology, and medicine, these materials are employed to integrate essential elements of materials science with a deep understanding of medical design.
The principal categories of medical engineered materials include medical plastics, medical foams, medical films, medical adhesives, and medical elastomers. Medical-grade plastic materials are formulated to produce items for medical applications. These materials find use in the manufacturing of products for in vitro diagnostics and primary packaging for pharmaceuticals, ensuring the preservation and containment of medicines to prevent contamination. The diverse applications span medical devices, medical disposables, medical wearables, and advanced wound care.
The medical engineered materials market consists of sales of medical plastics, medical foams, medical films, medical elastomers, and medical adhesives. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The medical engineered materials market size is expected to see rapid growth in the next few years. It will grow to $48.85 billion in 2030 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to increasing demand for next-generation implants, rising focus on regenerative medicine, expansion of personalized medical devices, growing use of sustainable medical materials, advancements in material engineering technologies. Major trends in the forecast period include increasing development of advanced biomaterials, rising use of customized medical polymers, growing demand for biocompatible and bioresorbable materials, expansion of engineered materials for implants, enhanced focus on material performance and safety.
The increasing volume of surgical procedures is anticipated to drive the expansion of the medical engineered materials market in the coming years. Surgical procedures are medical interventions that involve incisions or invasive techniques to diagnose or treat conditions affecting internal or external parts of the body. Growth in the number of surgeries directly increases the demand for materials used in surgical instruments, implantable devices, and minimally invasive interventions. Materials that are biocompatible and resistant to infection are critical to maintaining patient safety and improving clinical outcomes. At the same time, the need for customization and compliance with stringent regulatory requirements supports ongoing research and development activities, while cost considerations and technological progress continue to stimulate material innovation. For example, in June 2024, according to the American Society of Plastic Surgeons, a United States-based non-profit organization, minimally invasive procedures rose by 7% in 2023, exceeding the growth rate of traditional surgical procedures by 2%. Hand-related procedures, including carpal tunnel, arthritis, and trigger finger surgeries, reached 207,887 cases, representing a 2% increase compared to 2022. Therefore, the growing number of surgical procedures is contributing to the growth of the medical engineered materials market.
Major companies in the medical engineered materials market are investing in the development of new products to gain a competitive edge. Covestro AG, a Germany-based polymer materials company, introduced Makrolon 3638 polycarbonate in February 2023. This advanced material solution, tailored for healthcare and life sciences applications, exhibits high durability across a wide temperature range, from cryogenic to steam sterilization conditions. It features high impact strength and ductility, along with high chemical resistance, meeting medical-grade and biocompatibility standards. Suitable for skin contact applications, the material is also of food contact quality and can be sterilized using common methods in the healthcare sector.
In June 2023, STRATEC SE, a Germany-based healthcare technology company, completed the acquisition of Natech Plastics, Inc. for an undisclosed value. Through this transaction, STRATEC sought to enhance its footprint in the United States, broaden its customer portfolio, and capitalize on operational synergies in consumable technologies. Natech Plastics is a United States-based manufacturer specializing in the design and production of advanced polymer-based consumables used across medical technology, in vitro diagnostics, life sciences, consumer products, and specialized packaging applications.
Major companies operating in the medical engineered materials market are Evonik Industries AG, Covestro AG, BASF SE, Solvay SA, Saudi Basic Industries Corporation, Trelleborg AB, Koninklijke DSM N.V., Celanese Corporation, DuPont de Nemours Inc., Henkel AG & Co. KGaA, Huntsman Corporation, Momentive Performance Materials Inc., Nitto Denko Corporation, Recticel Ltd., Victrex plc, Ensinger GmbH, RTP Company, Foster Corporation, Zeus Industrial Products Inc., Saint-Gobain SA, Arkema SA, Eastman Chemical Company, Lubrizol Corporation, PolyOne Corporation, Quadrant AG, Röchling Group, DSM Biomedical, Invibio Ltd., Carpenter Technology Corporation, Heraeus Medical Components GmbH, CeramTec GmbH, Morgan Advanced Materials plc, Freudenberg Medical LLC.
Asia-Pacific was the largest region in the medical engineered materials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical engineered materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical engineered materials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the medical engineered materials market by increasing costs of imported specialty polymers, elastomers, adhesives, and processing equipment used in medical devices and disposables. North America and Europe are most affected due to dependence on imported high-performance materials, while Asia-Pacific faces cost pressure on export-driven material production. These tariffs are increasing material costs and affecting product pricing. However, they are also driving domestic material innovation, regional supplier development, and investment in localized biomaterial manufacturing.
The medical engineered materials market research report is one of a series of new reports that provides medical engineered materials market statistics, including medical engineered materials industry global market size, regional shares, competitors with a medical engineered materials market share, detailed medical engineered materials market segments, market trends and opportunities, and any further data you may need to thrive in the medical engineered materials industry. This medical engineered materials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Medical engineered materials, often referred to as biomaterials, denote substances that are specifically crafted to meet particular or customized criteria, aiming to interact with biological systems for therapeutic or diagnostic purposes in the field of medicine. Serving as a crucial link between science, technology, and medicine, these materials are employed to integrate essential elements of materials science with a deep understanding of medical design.
The principal categories of medical engineered materials include medical plastics, medical foams, medical films, medical adhesives, and medical elastomers. Medical-grade plastic materials are formulated to produce items for medical applications. These materials find use in the manufacturing of products for in vitro diagnostics and primary packaging for pharmaceuticals, ensuring the preservation and containment of medicines to prevent contamination. The diverse applications span medical devices, medical disposables, medical wearables, and advanced wound care.
The medical engineered materials market consists of sales of medical plastics, medical foams, medical films, medical elastomers, and medical adhesives. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Medical Engineered Materials Market Characteristics
3. Medical Engineered Materials Market Supply Chain Analysis
4. Global Medical Engineered Materials Market Trends and Strategies
5. Medical Engineered Materials Market Analysis of End Use Industries
7. Global Medical Engineered Materials Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Medical Engineered Materials Total Addressable Market (TAM) Analysis for the Market
9. Medical Engineered Materials Market Segmentation
10. Medical Engineered Materials Market Regional and Country Analysis
11. Asia-Pacific Medical Engineered Materials Market
12. China Medical Engineered Materials Market
13. India Medical Engineered Materials Market
14. Japan Medical Engineered Materials Market
15. Australia Medical Engineered Materials Market
16. Indonesia Medical Engineered Materials Market
17. South Korea Medical Engineered Materials Market
18. Taiwan Medical Engineered Materials Market
19. South East Asia Medical Engineered Materials Market
20. Western Europe Medical Engineered Materials Market
21. UK Medical Engineered Materials Market
22. Germany Medical Engineered Materials Market
23. France Medical Engineered Materials Market
24. Italy Medical Engineered Materials Market
25. Spain Medical Engineered Materials Market
26. Eastern Europe Medical Engineered Materials Market
27. Russia Medical Engineered Materials Market
28. North America Medical Engineered Materials Market
29. USA Medical Engineered Materials Market
30. Canada Medical Engineered Materials Market
31. South America Medical Engineered Materials Market
32. Brazil Medical Engineered Materials Market
33. Middle East Medical Engineered Materials Market
34. Africa Medical Engineered Materials Market
36. Medical Engineered Materials Market Competitive Landscape and Company Profiles
37. Medical Engineered Materials Market Other Major and Innovative Companies
40. Medical Engineered Materials Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Medical Engineered Materials Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses medical engineered materials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for medical engineered materials? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical engineered materials market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Medical Plastics; Medical Foams; Medical Films; Medical Adhesives; Medical Elastomer2) By Application: Medical Devices; Medical Disposables; Medical Wearables; Advanced Woundcare
3) By End-User Or Industry: Hospitals And Clinics; Diagnostic Laboratories; Pharmaceutical And Biotech Companies; Research And Academic Institutions; Home Healthcare And Personal Care
Subsegments:
1) By Medical Plastics: Polyethylene (PE); Polyvinyl Chloride (PVC); Polycarbonate (PC); Polypropylene (PP)2) By Medical Foams: Polyurethane Foams; Polyethylene Foams; Silicone Foams
3) By Medical Films: Thermoplastic Films; Biodegradable Films; Adhesive Films
4) By Medical Adhesives: Epoxy Adhesives; Cyanoacrylate Adhesives; Silicone Adhesives
5) By Medical Elastomers: Silicone Elastomers; Thermoplastic Elastomers (TPE); Polyurethane Elastomers
Companies Mentioned: Evonik Industries AG; Covestro AG; BASF SE; Solvay SA; Saudi Basic Industries Corporation; Trelleborg AB; Koninklijke DSM N.V.; Celanese Corporation; DuPont de Nemours Inc.; Henkel AG & Co. KGaA; Huntsman Corporation; Momentive Performance Materials Inc.; Nitto Denko Corporation; Recticel Ltd.; Victrex plc; Ensinger GmbH; RTP Company; Foster Corporation; Zeus Industrial Products Inc.; Saint-Gobain SA; Arkema SA; Eastman Chemical Company; Lubrizol Corporation; PolyOne Corporation; Quadrant AG; Röchling Group; DSM Biomedical; Invibio Ltd.; Carpenter Technology Corporation; Heraeus Medical Components GmbH; CeramTec GmbH; Morgan Advanced Materials plc; Freudenberg Medical LLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Medical Engineered Materials market report include:- Evonik Industries AG
- Covestro AG
- BASF SE
- Solvay SA
- Saudi Basic Industries Corporation
- Trelleborg AB
- Koninklijke DSM N.V.
- Celanese Corporation
- DuPont de Nemours Inc.
- Henkel AG & Co. KGaA
- Huntsman Corporation
- Momentive Performance Materials Inc.
- Nitto Denko Corporation
- Recticel Ltd.
- Victrex plc
- Ensinger GmbH
- RTP Company
- Foster Corporation
- Zeus Industrial Products Inc.
- Saint-Gobain SA
- Arkema SA
- Eastman Chemical Company
- Lubrizol Corporation
- PolyOne Corporation
- Quadrant AG
- Röchling Group
- DSM Biomedical
- Invibio Ltd.
- Carpenter Technology Corporation
- Heraeus Medical Components GmbH
- CeramTec GmbH
- Morgan Advanced Materials plc
- Freudenberg Medical LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 28.97 Billion |
| Forecasted Market Value ( USD | $ 48.85 Billion |
| Compound Annual Growth Rate | 13.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 34 |
